MELISSA PELC: Open Payments
NPI 1750870259 · PICKERINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 10 payments from 8 companies in 2025. Trend: 2023 $253 · 2024 $137 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $32 |
| ABBVIE INC. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Dexcom G6 Transmitter, LEQVIO, RELISTOR, XIFAXAN, Auvelity, Ozempic.
Industry payments across OH — which companies pay providers there.
